Socio-economic considerations in biosafety and biotechnology decision making: The Cartagena Protocol and National Biosafety frameworks

dc.creatorFalck-Zepeda, José B.
dc.creatorZambrano, Patricia
dc.date2011-03
dc.date2024-10-01T14:04:49Z
dc.date2024-10-01T14:04:49Z
dc.date.accessioned2026-06-27T15:03:49Z
dc.descriptionArticle 26.1 of the Cartagena Protocol on Biosafety left open the possibility for member countries to include in their biosafety regulatory processes the assessment of socio‐economic considerations. Countries may also decide to include such assessments as part of their national legislation or regulations for the approval and deliberate release into the environment of genetically engineered technologies. Countries are debating if and how to implement assessment of socio‐economic considerations. This paper contributes to the ongoing policy dialogue by discussing issues related to socio‐economic assessment including scope, timing, inclusion modalities, methods, decision‐making rules and standards, and the integration of socio‐economic assessments in biosafety and/or biotechnology approval processes. This paper also discusses the implications of such inclusion for technology flows and public and private sector R&D. If inclusion is not done properly, it may negatively impact technology flows especially from the public sector and render an unworkable biosafety system.
dc.identifierhttps://hdl.handle.net/10568/154921
dc.identifier.urihttp://hdl.handle.net/123456789/93453
dc.languageen
dc.publisherWiley
dc.rightsLimited Access
dc.sourceFalck-Zepeda, José Benjamin; Zambrano, Patricia. 2011. Socio-economic considerations in biosafety and biotechnology decision making: The Cartagena Protocol and National Biosafety frameworks. Review of Policy Research 28(2): 171-195. https://doi.org/10.1111/j.1541-1338.2011.00488.x
dc.subjectgenetically modified organisms
dc.subjectbiotechnology
dc.subjectbiosafety
dc.subjectsocioeconomics
dc.subjectimpact assessment
dc.subjectandean group
dc.subjectdeveloping countries
dc.titleSocio-economic considerations in biosafety and biotechnology decision making: The Cartagena Protocol and National Biosafety frameworks
dc.typeJournal Article

Archivos